Etoposide Injection 100mg

About Etoposide Injection 100mg

Etoposide Injection 100mg Uses

• Small cell lung cancer
• Testicular cancer
• Hodgkin lymphoma and non-Hodgkin lymphoma
• Acute myeloid leukemia
• Used in combination chemotherapy protocols for several other solid tumors

Etoposide Injection 100mg Benefits

• Slows down and stops the growth of fast dividing cancer cells
• Works well when combined with other chemotherapy drugs like cisplatin or carboplatin
• Helps shrink tumors before surgery or radiotherapy in some cancer protocols
• Improves overall survival outcomes when used as part of a complete treatment plan

What Experts Say

Oncologists select etoposide as part of combination chemotherapy regimens because it targets an enzyme cancer cells rely on to divide and repair their genetic material. This action works best during a specific phase of the cell cycle, which is why it rarely appears alone and is almost always paired with agents that work through different mechanisms.

Dosing decisions rest heavily on regular complete blood count monitoring, since bone marrow suppression is the most significant limiting factor for this drug. Physicians typically delay or reduce the next scheduled cycle if white cell or platelet counts drop below safe thresholds, and growth factor support is sometimes added so chemotherapy can continue on schedule.

Pakistan carries a considerable burden of lung, testicular, and lymphoid cancers, and etoposide based protocols remain a mainstay of treatment across public and private oncology units. Because this drug is a hospital administered infusion with a narrow safety margin, doctors insist on strict intravenous line monitoring and immediate access to supportive care.

Drug Class

• Topoisomerase II inhibitor
• Podophyllotoxin derivative
• Cytotoxic chemotherapy agent

Etoposide Injection 100mg formula

• Etoposide

Available forms

• Injection

How to use Etoposide Injection 100mg?

• Administered only by a qualified oncologist or trained hospital staff through a slow intravenous infusion.
• Never self-injected or used outside a hospital or clinic setting.
• Given as part of a structured chemotherapy cycle, usually over several consecutive days.
• Diluted with normal saline or dextrose solution before infusion, with the exact dilution decided by the treating team.
• Infusion rate is kept slow to reduce the risk of low blood pressure during administration.
• Dose is calculated based on body surface area, body weight, and recent blood counts before each cycle.

Drug Interactions

• Other bone marrow suppressing drugs or radiotherapy can add up and worsen low blood counts.
• Live vaccines should be avoided during treatment since immune suppression raises the risk of a serious vaccine related infection.
• Cyclosporine and certain other immunosuppressants can raise etoposide levels in the blood and increase toxicity.
• Warfarin and other blood thinners may need closer monitoring since etoposide can affect clotting and platelet counts.
• Cisplatin given before etoposide can slow how quickly the body clears it, requiring dose adjustment.
• Phenytoin and certain other anti-seizure medicines can lower etoposide levels and reduce its effectiveness.
• Grapefruit and grapefruit juice may affect drug metabolism and should be discussed with the treating oncologist.

Risks and warnings

• Severely lowers white blood cells, red blood cells, and platelets, raising the risk of infection, anemia, and bleeding.
• Neutropenia (low white cell count) can lead to serious, sometimes life threatening infections, most commonly seven to fourteen days after a dose.
• May cause allergic reactions during infusion, including chills, fever, low blood pressure, or breathing difficulty.
• Long term or high cumulative dose use carries a small but recognized risk of treatment related leukemia years later.
• Can harm an unborn baby and may affect fertility in both men and women, so effective contraception is advised during and after treatment.
• Existing liver or kidney disease changes how the body clears this drug, so dose adjustment and close monitoring are required.
• Leakage of the drug outside the vein during infusion can damage surrounding tissue and needs immediate medical attention.
• Never given to patients with severe bone marrow suppression or an active uncontrolled infection until blood counts recover.

Etoposide Injection 100mg Side Effects

• Nausea and vomiting
• Hair loss
• Loss of appetite
• Mouth sores
• Fatigue and weakness
• Low blood counts, including anemia, low platelets, and low white blood cells
• Fever and chills during or shortly after infusion
• Diarrhea
• Low blood pressure if the infusion runs too quickly
• Tingling or numbness in the hands and feet with prolonged use
• Temporary metallic taste or altered sense of taste

Storage Conditions

• Store unopened vials between 15°C and 25°C, away from direct light.
• Keep in the original carton until the oncology pharmacy prepares the dose.
• Do not freeze the injection solution.
• Diluted infusion solution must be used within the time specified by the hospital pharmacy, usually within a few hours.
• Keep out of reach of children at all times.
• Dispose of used vials and equipment through proper cytotoxic waste handling procedures.